BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 749
- Registration Number
- NCT00683865
Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 383
- Registration Number
- NCT00682019
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2014-12-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 45
- Registration Number
- NCT00681551
Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 333
- Registration Number
- NCT00681772
Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
- First Posted Date
- 2008-05-20
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 7
- Registration Number
- NCT00680654
BAY38-9456 - Pivotal Trial for Diabetes Patient
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 790
- Registration Number
- NCT00678704
A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT00678288
Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 276
- Registration Number
- NCT00676533
A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 60
- Registration Number
- NCT00674115
Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 105
- Registration Number
- NCT00673686
© Copyright 2024. All Rights Reserved by MedPath